Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines

Proceedings of the Society for Experimental Biology and Medicine

Volumn 223, Issue 4, 2000, Pages 379-388

  Savre Train, Isabelle ^a   Gollahon, Lauren S ^b   Holt, Shawn E ^c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN; RNA; TELOMERASE;

ARTICLE; CELL CLONE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SUBUNIT; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; RNA ANALYSIS; TELOMERE; TUMOR CELL CULTURE;

EID: 0034031373     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22354.x     Document Type: Article

References (46)

1. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59:521-529, 1989.
2. Moyzis RK, Buckingham JM, Cram S, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu J-R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 85:6622-6626, 1988.
3. de Lange T, Shiue L, Meyers RM, Cox DR, Naylor SL, Killery AM, Varmus HE. Structure and variability of human chromosome ends. Mol Cell Biol 10:518-527, 1990.
4. Blackburn EH. Structure and function of telomeres. Nature 350:569-573, 1991.
5. Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Doklady Biochem 201:394-397, 1971.
6. Watson JD. Origin of concatameric T4 DNA. Nature New Biol 239:197-201, 1972.
7. Harley CB, Futcher AB, Greider CW. Telomeres shorten with aging. Nature 345:458-460, 1990.
8. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868, 1990.
9. Lindsey J, McGill N, Lindsey L, Green D, Cooke H. In vivo loss of telomeric repeats with age in humans. Mutat Res 256:45-48, 1991.
10. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Youglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 89:10114-10118, 1992.
11. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27:383-389, 1992.
12. Nakamura TM, Morin GB, Chapman B, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997.
13. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 90:785-795, 1997.
14. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, Mar V, Bass MB, Robinson MO. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11:3109-3115, 1997.
15. Kilian A, Bowtell DDL, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019, 1997.
16. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chui C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of lifespan by introduction of telomerase into normal human cells. Science 279:349-352, 1998.
17. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8:279-282, 1998.
18. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791, 1997.
19. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
20. Piatyszek MA, Kim NW, Weinrich SL, Keiko H, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17:1-15, 1995.
21. Counter CM, Avilion AA, Lefeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929, 1992.
22. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179, 1996.
23. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 92:9082-9086, 1995.
24. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematological malignancies. Blood 85:2315-2320, 1995.
25. Hiyama K, Hirai Y, Kyoizumi S, Akiyamam M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715, 1995.
26. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, Yokoyama T. Telomerase activity in human intestine. Int J Oncol 9:453-458, 1996.
27. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106:759-765, 1996.
28. Bodnar AG, Kim NW, Effros RB, Chui C-P. Mechanisms of telomerase induction during T-cell activation. Exp Cell Res 228:58-64, 1996.
29. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 13:4953-4962, 1994.
30. Bryan TM, Engelzou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal cells without detectable telomerase activity. EMBO J 14:4240-4248, 1995.
31. Shay JW, West MD, Wright WE. Re-expression of senescent markers in deinduced reversibly immortalized cells. Exp Gerontol 27:477-492, 1992.
32. Gollahon LS, Shay JW. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12:715-725, 1996.
33. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 15:425-432, 1995.
34. Miller AD, Rosman G. Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990, 1989.
35. Morgenstern JP, Land H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587-3596, 1990.
36. Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 18:237-248, 1996.
37. Norton JC, Holt SE, Wright WE, Shay JW. Enhanced detection of human telomerase activity. DNA Cell Biol 17:217-219, 1998.
38. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
39. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. The RNA component of human telomerase. Science 269:1236-1241, 1995.
40. Ohmura H, Tahara H, Suzuki M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86:899-904, 1995.
41. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Toft DO, Trager JB, Morin GB, Wright WE, Shay JW, White MA. Functional requirement of p23 and hsp90 in telomerase complexes. Genes Dev 13:817-827, 1999.
42. Bryan TM, Engelzou A, Dunham MA, Reddel RR. Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res 239:370-378, 1998.
43. Jones CJ, Soley A, Skinner JW, Gupta J, Haughton MF, Wyllie FS, Schlumberger M, Bacchetti S, Wynford-Thomas D. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res 240:333-339, 1998.
44. Shore D. Telomere length regulation: Getting the measure of chromosome ends. Biol Chem 378:591-597, 1997.
45. Van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743, 1997.
46. Van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 98:401-403, 1998.